Overview
Prothrombin gene mutation is treated with 1 medication in our database, including ARGATROBAN. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mitsubishi Tanabe. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Prothrombin gene mutation treatment below.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
2 eventsHospices Civils de Lyon
City Therapeutics — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableARGATROBAN
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Clinical Trials
View all trials with filters →No actively recruiting trials found for Prothrombin gene mutation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
1 grantsCommunity
No community posts yet. Be the first to share your experience with Prothrombin gene mutation.
Start the conversation →Latest news about Prothrombin gene mutation
Disease timeline:
New recruiting trial: A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation
A new clinical trial is recruiting patients for Prothrombin gene mutation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Prothrombin gene mutation
What is Prothrombin gene mutation?
Prothrombin gene mutation is treated with 1 medication in our database, including ARGATROBAN. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mitsubishi Tanabe. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Prothrombin gene mutation treatment below.
How is Prothrombin gene mutation inherited?
Prothrombin gene mutation follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Prothrombin gene mutation typically begin?
Typical onset of Prothrombin gene mutation is adult. Age of onset can vary across affected individuals.
Which specialists treat Prothrombin gene mutation?
1 specialists and care centers treating Prothrombin gene mutation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Prothrombin gene mutation?
1 FDA-approved treatment are currently tracked on UniteRare for Prothrombin gene mutation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.